GL1X · GenesisL1 explorer

MolNFT v1 · #13919 · protein

Crystal structure of plasmepsin IV from P. falciparum in complex with pepstatin a

1LS5: “Crystal structure of plasmepsin IV from P. falciparum in complex with pepstatin a”. X-ray diffraction, 1 ligand (IVA), 3 pockets (best druggability 0.87). MolNFT v1 #13919 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
1LS5
Type
protein
Length
666 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Plasmepsin IV; Pepstatin
UniProt
Q8IM16
Ligands
IVA
Pockets
3 · best druggability 0.87

Structure

x-ray diffraction · 2 distinct chains · 11% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPlasmepsin IVprotein32811% helix, 38% strandQ8IM16
C, DPepstatinprotein50% helix, 40% strand—

Ligands and binding sites

  • IVA · Isovaleric acid · ligand · 2 copies · chains A, C, B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19670.870.88100IVA
2560.540.8813empty
3580.300.7614empty

Interfaces

4 interfaces between chains.

  • A–B · 1193 Ų buried · 9 hydrogen bonds · protein-protein
  • A–C · 620 Ų buried · 17 hydrogen bonds · protein-protein
  • B–D · 566 Ų buried · 14 hydrogen bonds · protein-protein
  • A–D · 104 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 4 modified, 2 covalent (disulfide, nonstandard, covalent ligand).

Compared structures

  • 1LS5 · Crystal structure of plasmepsin IV from P. falciparum in complex with pepstatin A · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.